July 7, 2011 – Sprockhövel Germany and Budapest, Hungary, London, UK, Princeton NJ – Axel Semrau and ThalesNano today announced the signing of a collaboration agreement for product distribution in the territory of Germany.

“We are very proud and excited about partnering with Axel Semrau. is a leading distributor for analytical instruments in Germany – said Dr. Ferenc Darvas, president and chairman of ThalesNano Inc. – “Our business in the region has been growing very rapidly and Axel Semrau will be providing our customers with high quality support that Axel Semrau is well known for.”

“We are looking to provide innovative solutions for our pharmaceutical, agrochemical, chemical and academic customers”, Norbert Wenkel, CEO and Director o Sales of Axel Semrau, said. “ThalesNano’s award winning continuous chemistry products for organic synthesis offer users dramatic speed improvements, safety, rapid scale up, and the ability to expand the chemical space.”

About ThalesNano Inc.:
ThalesNano www.thalesnano.com is a world-leading provider of continuous process chemistry instruments in the rapidly developing market of laboratory and process scale flow reactors. The company has the widest portfolio of bench-top continuous process instruments. Its R&D 100 award winning H-Cube® continuous-flow hydrogenation reactor and the pilot plant scale version H-Cube Mid™ are used in hundreds of laboratories in four continents and have become the new industry standard for hydrogenation.

Contact: Laszlo Urge, Ph.D., CEO, e-mail: ceodirect@thalesnano.com, Telephone: +36-1-880-8500

About Axel Semrau GmbH & Co KG:
Axel Semrau GmbH & Co. KG, www.axel-semrau.de is one of the largest trading companies and service providers in Germany in the area of instrument-based analysis. For more than 30 years, Axel Semrau® and his team have been active in the sale and support of special solutions for chromatography, mass spectrometry and chemical synthesis, as well as application-optimised workstations in the whole of Germany. Automation of chromatography is one main focus of the company. In order to offer unique and superior automation solutions Axel Semrau® generates own software solutions. Product developments like specialized chromatography software solutions and products for odorization control are marketed and sold throughout the world.

Under the motto “We sense good chemistry …” the company and its staff are committed to exceptional customer support quality.

Contact: Norbert Wenkel, CEO Sales and Marketing, e-mail: wenkel@axelsemrau.de, Telephone: +49 2339 12090

BUDAPEST, HUNGARY, PRINCETON, NJ and LONDON, UK –(12 May, 2011)

ThalesNano today reported that the China Patent and Trademark Office (CPO) has granted a patent for its flow ozonolysis instrument, the O-Cube™, including several aspects of its proprietary underlying technology.

Ozonolysis is a fundamentally important oxidation reaction, which has never been fully adopted due to the safety concerns with performing the process. The O-Cube™ reinvents the use of ozone in chemical reactions by enabling safe, fast and cost-efficient ozonolysis with superior yields when compared to conventional methods. The O-Cube™’s low temperature capability means the system is also able to perform other types of hazardous reactions in the same compact reactor, dramatically increasing its potential utility.

Dr. Laszlo Urge, CEO of ThalesNano, said, “We are delighted that the CPO has granted us full patent approval for the O-Cube™. Since launching our first instrument, the H-Cube®, in 2004, this is the second time that China, a market leading country, has recognized the importance of patenting such a disruptive technology.”

Richard Jones, Head of R&D and Product Management added: “Our technology is utilized successfully in 32 countries worldwide and has made a dramatic impact in increasing the level of safety of hazardous processes allowing chemists to tap into previously forbidden chemistries. China is a country of enormous potential for us and this patent will give us the confidence to fully implement this technology into the region, helping Chinese chemists to gain the same benefits that chemists in other countries have already been exploiting. We will continue to pursue patent protection for the O-Cube™ in other geographies.”

About ThalesNano Inc.
ThalesNano is the world leader in bench-top flow chemistry reactors. The company has the widest portfolio of continuous process instruments for the pharmaceutical, biotech, fine chemical, petroleum/biofuel, and education markets. Its R&D 100 award winning H-Cube® and scale-up system H-Cube Mid™ are used in hundreds of laboratories globally and have become the new industry standard for hydrogenation. Within three years from the original introduction of its flagship H-Cube® product, 20 out of the top 20 pharmaceutical companies have introduced and adopted the technology.

Contact: ceodirect@thalesnano.com for more information.